Genix Pharmaceuticals GENPF Stock
Genix Pharmaceuticals Price Chart
Genix Pharmaceuticals GENPF Financial and Trading Overview
| Genix Pharmaceuticals stock price | 0.04 USD |
| Previous Close | 0.04 USD |
| Open | 0.04 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.04 - 0.04 USD |
| 52 Week Range | 0.007 - 0.25 USD |
| Volume | 1K USD |
| Avg. Volume | 50 USD |
| Market Cap | 2.45M USD |
| Beta (5Y Monthly) | -0.882154 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GENPF Valuation Measures
| Enterprise Value | 2.51M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1546.244 |
| Price/Book (mrq) | 0.74799997 |
| Enterprise Value/Revenue | 1583.582 |
| Enterprise Value/EBITDA | -7.063 |
Trading Information
Genix Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -0.882154 |
| 52-Week Change | -37.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.25 USD |
| 52 Week Low | 0.007 USD |
| 50-Day Moving Average | 0.11 USD |
| 200-Day Moving Average | 0.07 USD |
GENPF Share Statistics
| Avg. Volume (3 month) | 50 USD |
| Avg. Daily Volume (10-Days) | 300 USD |
| Shares Outstanding | 59.22M |
| Float | 33.27M |
| Short Ratio | N/A |
| % Held by Insiders | 44.66% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -56341.15% |
| Gross Margin | 52.14% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.81% |
| Return on Equity (ttm) | -28.33% |
Income Statement
| Revenue (ttm) | 1.58K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -354683 USD |
| Net Income Avi to Common (ttm) | -962539 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.29K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 331.53K USD |
| Total Debt/Equity (mrq) | 11.16 USD |
| Current Ratio (mrq) | 0.239 |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -240497 USD |
| Levered Free Cash Flow (ttm) | 92.8K USD |
Profile of Genix Pharmaceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1055 West Hastings Street |
| ZIP | V6E 2E9 |
| Phone | 604 609 6198 |
| Website | https://www.genixpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that manages blood sugar. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Q&A For Genix Pharmaceuticals Stock
What is a current GENPF stock price?
Genix Pharmaceuticals GENPF stock price today per share is 0.04 USD.
How to purchase Genix Pharmaceuticals stock?
You can buy GENPF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genix Pharmaceuticals?
The stock symbol or ticker of Genix Pharmaceuticals is GENPF.
Which industry does the Genix Pharmaceuticals company belong to?
The Genix Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Genix Pharmaceuticals have in circulation?
The max supply of Genix Pharmaceuticals shares is 65.43M.
What is Genix Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Genix Pharmaceuticals PE Ratio is now.
What was Genix Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Genix Pharmaceuticals EPS is -0.05 USD over the trailing 12 months.
Which sector does the Genix Pharmaceuticals company belong to?
The Genix Pharmaceuticals sector is Healthcare.